Cerebrospinal fluid interleukin-6 levels: A possible marker of disease activity [5]

Annals of Neurology

Volumn 50, Issue 6, 2001, Pages 828-

  Jellinger, Kurt A ^a   Rösler, Norbert ^a   Wichart, Ildiko ^a  

^a OTTO WAGNER HOSPITAL   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 6;

ALZHEIMER DISEASE; ASTROCYTE; CEREBROSPINAL FLUID ANALYSIS; CHILD; DEMENTIA; DISEASE ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HYPERTENSION ENCEPHALOPATHY; IMMUNOREACTIVITY; LETTER; MEASUREMENT; MICROGLIA; PARAMETER; PRIORITY JOURNAL;

AGED; ALZHEIMER DISEASE; BIOLOGICAL MARKERS; CENTRAL NERVOUS SYSTEM DISEASES; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; INTERLEUKIN-6;

EID: 0035202811     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.10017     Document Type: Letter

References (5)

1. Cerebrospinal fluid interleukin-6 levels in hypertensive encephalopathy: A possible marker of disease activity
2. Intra vitam lumbar and post mortem ventricular cerebrospinal fluid immunoreactive interleukin-6 in Alzheimer's disease patients
3. Interleukin-6 is not altered in cerebrospinal fluid of first-degree relatives and patients with Alzheimer's disease
4. Decreased interleukin-6 level in the cerebrospinal fluid of patients with Alzheimer-type dementia
5. Interleukin-6 (IL-6) and soluble forms of IL-6 receptors are not altered in cerebrospinal fluid of Alzheimer's disease patients